These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11687713)

  • 1. Central nervous system: review of clinical use of contrast media.
    Runge VM; Muroff LR; Jinkins JR
    Top Magn Reson Imaging; 2001 Aug; 12(4):231-63. PubMed ID: 11687713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gd DTPA: a review of clinical indications in central nervous system magnetic resonance imaging.
    Runge VM; Carollo BR; Wolf CR; Nelson KL; Gelblum DY
    Radiographics; 1989 Sep; 9(5):929-58. PubMed ID: 2678298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast enhancement issues in the MR evaluation of the central nervous system.
    Colosimo C; Manfredi R; Tartaglione T
    Eur Radiol; 1997; 7 Suppl 5():231-7. PubMed ID: 9370549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of MR contrast in nonneoplastic disease of the brain.
    Runge VM
    Top Magn Reson Imaging; 1995; 7(3):158-67. PubMed ID: 7654394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic principles of MR contrast.
    Nelson KL; Runge VM
    Top Magn Reson Imaging; 1995; 7(3):124-36. PubMed ID: 7654392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced MRI of the central nervous system: comparison between gadodiamide injection and gadolinium-DTPA.
    Akeson P; Jonsson E; Haugen I; Holtås S
    Neuroradiology; 1995 Apr; 37(3):229-33. PubMed ID: 7603600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of MR contrast in neoplastic disease of the brain.
    Muroff LR; Runge VM
    Top Magn Reson Imaging; 1995; 7(3):137-57. PubMed ID: 7654393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pitfalls of contrast-enhanced imaging in the nervous system.
    Brant-Zawadzki M
    Magn Reson Med; 1991 Dec; 22(2):243-8. PubMed ID: 1812353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giant extra-adrenal pheochromocytoma: magnetic resonance imaging with gadolinium-DTPA enhancement.
    Terk MR; de Verdier H; Colletti PM
    Magn Reson Imaging; 1993; 11(1):47-50. PubMed ID: 8423721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of gadoteridol for magnetic resonance imaging of the brain and spine.
    Runge VM; Bronen RA; Davis KR
    Invest Radiol; 1992 Aug; 27 Suppl 1():S22-32. PubMed ID: 1506150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of gadolinium-diethylenetriaminepentaacetic acid in the evaluation of the central nervous system.
    Runge VM; Gelblum DY
    Magn Reson Q; 1990 Apr; 6(2):85-107. PubMed ID: 2202425
    [No Abstract]   [Full Text] [Related]  

  • 12. Gadolinium-DTPA enhanced MRI in neonatal osteomyelitis of the cervical spine.
    Martijn A; van der Vliet AM; van Waarde WM; van Aalderen WM
    Br J Radiol; 1992 Aug; 65(776):720-2. PubMed ID: 1393402
    [No Abstract]   [Full Text] [Related]  

  • 13. Magnetic resonance imaging of the central nervous system in children with a new nonionic gadolinium contrast agent--gadoteridol injection (ProHance).
    Byrd SE; Darling CF; Wilczynski MA
    J Natl Med Assoc; 1993 May; 85(5):361-6. PubMed ID: 8496990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging with gadolinium-DTPA enhancement in the differentiation of benign from neoplastic cord cavitation.
    Clarke CE; Hawnaur J; Prvulovich E; Yuill GM; Bannister CM
    Clin Radiol; 1990 Mar; 41(3):214-6. PubMed ID: 2323169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of dotarem (Gd-DOTA) versus magnevist (Gd-DTPA) in magnetic resonance imaging of the central nervous system.
    Oudkerk M; Sijens PE; Van Beek EJ; Kuijpers TJ
    Invest Radiol; 1995 Feb; 30(2):75-8. PubMed ID: 7782190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Principles of contrast enhancement in the evaluation of brain diseases: an overview.
    Runge VM; Muroff LR; Wells JW
    J Magn Reson Imaging; 1997; 7(1):5-13. PubMed ID: 9039588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical applications of contrast agents in body imaging.
    Bydder GM
    Top Magn Reson Imaging; 1991 Mar; 3(2):74-84. PubMed ID: 2025434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging contrast agents.
    Runge VM
    Curr Opin Radiol; 1992 Feb; 4(1):3-12. PubMed ID: 1739599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of Omniscan (gadodiamide) in magnetic resonance studies of the central nervous system (results of a multicenter study)].
    Sinitsyn VE; Kornienko VN; Nikitin VG; Pronin IN; Ternovoĭ SK; Tiutin LA; Iakobson MG
    Vestn Rentgenol Radiol; 1995; (4):5-11. PubMed ID: 8571538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of contrast enhancement with Gd-DTPA in MRI of brain tumors. A comparison with X-ray CT].
    Tsuji T; Kishikawa T; Ikezaki K; Fujii K; Matsumoto S; Koga T
    Fukuoka Igaku Zasshi; 1987 Dec; 78(12):578-97. PubMed ID: 3447928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.